BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15480259)

  • 1. [Hematodermic CD4/CD56 neoplasm].
    Petrella T; Wechsler J; Courville P; de Muret A; Bosq J; Déchelotte P; Feuillard J; Durlach A; Vergier B
    Ann Pathol; 2004 Jun; 24(3):241-55; quiz 227. PubMed ID: 15480259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases].
    Machet L; De Muret A; Wiezberka E; Bernez A; Abdallah-Lotf M; Linassier C; Petrella T
    Ann Dermatol Venereol; 2004 Nov; 131(11):969-73. PubMed ID: 15602384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes.
    Petrella T; Comeau MR; Maynadié M; Couillault G; De Muret A; Maliszewski CR; Dalac S; Durlach A; Galibert L
    Am J Surg Pathol; 2002 Jul; 26(7):852-62. PubMed ID: 12131152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.
    Petrella T; Bagot M; Willemze R; Beylot-Barry M; Vergier B; Delaunay M; Meijer CJ; Courville P; Joly P; Grange F; De Muret A; Machet L; Dompmartin A; Bosq J; Durlach A; Bernard P; Dalac S; Dechelotte P; D'Incan M; Wechsler J; Teitell MA
    Am J Clin Pathol; 2005 May; 123(5):662-75. PubMed ID: 15981806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.
    Jaye DL; Geigerman CM; Herling M; Eastburn K; Waller EK; Jones D
    Mod Pathol; 2006 Dec; 19(12):1555-62. PubMed ID: 16998465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agranular CD4+/CD56+ hematodermic neoplasm: a distinct entity described in the recent World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas.
    Niakosari F; Sur M
    Arch Pathol Lab Med; 2007 Jan; 131(1):149-51. PubMed ID: 17227117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin.
    Herling M; Teitell MA; Shen RR; Medeiros LJ; Jones D
    Blood; 2003 Jun; 101(12):5007-9. PubMed ID: 12576313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
    Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
    Kato N; Yasukawa K; Onozuka T; Kikuta H
    J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
    Herling M; Jones D
    Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases.
    Ascani S; Massone C; Ferrara G; Rongioletti F; Papini M; Pileri S; Cerroni L
    J Cutan Pathol; 2008 Oct; 35(10):911-5. PubMed ID: 18494823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biologic features of CD4(+)CD56(+) malignancies.
    Feuillard J; Jacob MC; Valensi F; Maynadié M; Gressin R; Chaperot L; Arnoulet C; Brignole-Baudouin F; Drénou B; Duchayne E; Falkenrodt A; Garand R; Homolle E; Husson B; Kuhlein E; Le Calvez G; Sainty D; Sotto MF; Trimoreau F; Béné MC
    Blood; 2002 Mar; 99(5):1556-63. PubMed ID: 11861268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
    Yang X; Wasserman PG; Bhargava A; Iqbal U; Ragnauth S; Fuchs A
    Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification.
    Karube K; Ohshima K; Tsuchiya T; Yamaguchi T; Suefuji H; Suzumiya J; Harada M; Kikuchi M
    Am J Surg Pathol; 2003 Oct; 27(10):1366-74. PubMed ID: 14508398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman.
    Chang SE; Choi HJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
    Am J Dermatopathol; 2002 Feb; 24(1):72-5. PubMed ID: 11803287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agranular CD4+/CD56+ cutaneous neoplasm.
    Touahri T; Belaouni H; Mossafa H; Pulik M; Bourguigna L; Ibbora C; Dal Soglio D; Davi F; Fourcade C
    Leuk Lymphoma; 2002 Jul; 43(7):1475-9. PubMed ID: 12389632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blastic natural killer (NK)-cell lymphoma: report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature.
    Argyrakos T; Rontogianni D; Karmiris T; Kapsimali V; Grigoriou E; Tsantekidou M; Naum C; Galani V; Pantelidaki C; Harhalakis N; Nikiforakis E; Kanavaros P
    Leuk Lymphoma; 2004 Oct; 45(10):2127-33. PubMed ID: 15370260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ CD56+ blastic tumor of the skin: cytogenetic observations and further evidence of an origin from plasmocytoid dendritic cells.
    Hallermann C; Middel P; Griesinger F; Gunawan B; Bertsch HP; Neumann C
    Eur J Dermatol; 2004; 14(5):317-22. PubMed ID: 15358570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.